… Also, a report based on the World Health Organization’s VigiBase search revealed five
unique cases of rhabdomyolysis resulting from concomitant treatment with ticagrelor and …

… concomitant noncytotoxic medications are administered. … conditions, details of other
concomitant treatments, and little or … and treatments and includes patient demographics, treatment …

… The prediction model described herein can enable physicians to better monitor patients at
high risk for TD and recommend appropriate treatment plans to help maintain quality of life. …

… We assessed concomitant ASA use and its association with clinical outcomes among AF
patients treated … We assessed concomitant ASA use and its association with clinical outcomes …

… concomitant treatment improved the outcome of patients with LAHNSCC without compromising
compliance to the concomitant treatments… to assess the OS of concomitant treatment with …

… We reviewed the literature to assess DDIs reported for the main drugs available for
treatment of symptoms/comorbidities frequently encountered by cancer patients. Reviews and …

… We also investigated whether VAR concomitantly administered with ADs increases the risk
of SRE (Study 2). In addition, we investigated whether the use of VAR alone is a latent risk …

… The authors sought to assess whether this beneficial effect can be generalized to a more …
with citalopram treatment alone. We also tested the effect of concomitant treatment with any …

… We assessed the prevalence and treatment of patients with hypertension and ⩾3 additional
CV risk factors in The Netherlands and Italy in a retrospective cohort study using the …

… treatments, and use diverse neuropathy assessments, some … concomitant medications
and physiopathologic factors associated with PIPN in a cohort of more than 500 paclitaxel‐treated …